Participated in ImmuneBridge's $7.7M Seed round for scalable cell therapy manufacturing, co-investing with NFX, M Ventures, and Insight Partners.
ImmuneBridge is building a next-generation platform for cell therapy development, utilizing umbilical cord blood stem cells and machine learning to enhance therapeutic efficacy and scalability
ImmuneBridge is building a next-generation platform for cell therapy development, utilizing umbilical cord blood stem cells and machine learning to enhance therapeutic efficacy and scalability.